EGFR and lung carcinoma: Albeit within a relatively small number of lung cancer samples, gene amplification and overexpression of MAPK7 appeared to be a distinct molecular feature, as of the 3 samples, only 1 contained an EGFR L858R mutation and none had KRas mutation (data not shown).